Jounce Therapeu CVR Contra Cus
13F holders, Q2 2024 (June 30)2holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Jounce Therapeu CVR Contra Cus in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Moloney Securities Asset Management, LLC ($0) and Erste Asset Management GmbH ($0).
- Company
- Jounce Therapeu CVR Contra Cus
- CUSIP
- 481CVR017
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Moloney Securities Asset Management, LLC | 0.00% | No change | 176,450 | $0 |
| Erste Asset Management GmbH | 0.00% | No change | 1,559,587 | $0 |
"% of holder's portfolio" is JOUNCE THERAPEU CVR CONTRA CUS's weight in each manager's 13F, not the share of Jounce Therapeu CVR Contra Cus the manager owns.